首页 | 本学科首页   官方微博 | 高级检索  
     


Randomized,Double-Blinded,Placebo-Controlled,Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy
Authors:Richard Choo  Himu Lukka  Patrick Cheung  Tom Corbett  Rosario Briones-Urbina  Reinhold Vieth  Lisa Ehrlich  Alex Kiss  Cyril Danjoux
Affiliation: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; Department of Radiation Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Canada; Department of Radiation Oncology, Odette Cancer Centre, University of Toronto, Toronto, Canada;§ Department of Medicine, Women''s College Hospital, University of Toronto, Toronto, Canada; Departments of Nutritional Sciences and Laboratory Medicine and Pathology, Mount Sinai Hospital, University of Toronto, Toronto, Canada; Department of Radiology, Sunnybrook Health Sciences Center, University of Toronto, Canada;# Department of Health Policy, Management, and Evaluation, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号